0000950170-24-099833.txt : 20240822 0000950170-24-099833.hdr.sgml : 20240822 20240822160558 ACCESSION NUMBER: 0000950170-24-099833 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240820 FILED AS OF DATE: 20240822 DATE AS OF CHANGE: 20240822 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Musso Alan A CENTRAL INDEX KEY: 0001295830 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38130 FILM NUMBER: 241232022 MAIL ADDRESS: STREET 1: FULCRUM THERAPEUTICS, INC. STREET 2: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aileron Therapeutics, Inc. CENTRAL INDEX KEY: 0001420565 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 134196017 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12407 N. MOPAC EXPY. STREET 2: SUITE 250 #390 CITY: AUSTIN STATE: TX ZIP: 78758 BUSINESS PHONE: 7378021989 MAIL ADDRESS: STREET 1: 12407 N. MOPAC EXPY. STREET 2: SUITE 250 #390 CITY: AUSTIN STATE: TX ZIP: 78758 FORMER COMPANY: FORMER CONFORMED NAME: AILERON THERAPEUTICS INC DATE OF NAME CHANGE: 20071207 4 1 ownership.xml 4 X0508 4 2024-08-20 0001420565 Aileron Therapeutics, Inc. ALRN 0001295830 Musso Alan A C/O AILERON THERAPEUTICS, INC 12407 N. MOPAC EXPY. SUITE 250 #390 AUSTIN TX 78758 true false false false false Stock Option (right to buy) 2.40 2024-08-20 4 A false 2725 0.00 A 2034-08-19 Common Stock 2725 2725 D This option was granted on August 20, 2024. The shares underlying the option are scheduled to vest in full on the earlier of (i) August 20, 2025 or (ii) the date of the Issuer's 2025 Annual Meeting of Stockholders. /s/ Brian Windsor, attorney-in-fact for Alan A. Musso 2024-08-22